| 项目/年度 | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业收入（百万元） | 22,427 | 22,772 | 23,722 | 24,717 | | 增长率（%） | 5.3 | 1.5 | 4.2 | 4.2 | | 归属母公司股东净利润（百万元） | 2,244 | 2,097 | 2,197 | 2,281 | | 增长率（%） | 3.0 | -6.6 | 4.8 | 3.8 | | 每股收益（元） | 2.80 | 2.62 | 2.74 | 2.85 | | PE | 16 | 17 | 16 | 16 | | PB | 5.6 | 5.7 | 5.6 | 5.6 | 资料来源：Wind，国联民生证券研究所预测；（注：股价为 2026 年 2 月 24 日收盘价） 2026 年 02 月 25 日 苏泊尔(002032.SZ)2025 年业绩快报点评 全年营收稳健收官，费用投放拖累业绩 glmszqdatemark [盈利预测与财务指标 Table_Forcast] | 推荐 | 维持评级 | | ...

苏泊尔(002032.SZ)2025 年业绩快报点评 全年营收稳健收官，费用投放拖累业绩 glmszqdatemark [盈利预测与财务指标 Table_Forcast] [Table_Author] 分析师 管泉森 执业证书： S0590523100007 邮箱： guanqs@glms.com.cn | 分析师 | 孙珊 | | --- | --- | | | 执业证书： S0590523110003 | | 邮箱： | sunshan@glms.com.cn | | 分析师 | 周振 | | | 执业证书： S0590526010001 | | 邮箱： | zhouzhen@glms.com.cn | 相对走势 -20% -3% 13% 30% 苏泊尔 沪深300 相关研究 1． 苏泊尔 2025 年三季报点评：收入展现韧 性，业绩波动无需过忧-2025/10/24 本公司具备证券投资咨询业务资格，请务必阅读最后一页免责声明 证券研究报告 1 | 项目/年度 | 2024A | 2025E | 2026E | 2027E | | --- | --- | --- | --- | --- | | 营业收入（ ...

Performance Summary - Supor reported a net profit of 2.097 billion yuan for 2025, a decrease of 6.58% year-on-year [2] - Sanofi reported a net profit of 2.939 billion yuan for 2025, an increase of 317.09% year-on-year [17] - Wens Foodstuff Group reported a net profit of 5.235 billion yuan for 2025, a decrease of 43.59% year-on-year [18] - Sree New Materials reported a net profit of 154 million yuan for 2025, an increase of 35.04% year-on-year [22] - JiaoKong Technology reported a net profit of 156 million yuan for 2025, an increase of 86.13% year-on-year [22] - Aidi Pharmaceutical reported a net loss of 19.7337 million yuan for 2025, a reduction in loss [22] - MicroGuide Nano reported a net profit of 213 million yuan for 2025, a decrease of 6.12% year-on-year [22] - Zhongwei Semiconductor reported a net profit of 285 million yuan for 2025, an increase of 108.05% year-on-year [22] - Hengyu Environmental reported a net profit of 35.9325 million yuan for 2025, an increase of 106.25% year-on-year [22] - Zhongke Shuguang reported a net profit attributable to shareholders of 2.113 billion yuan for 2025, an increase of 10.54% year-on-year [22] - Oat Technology reported a net profit of 137 million yuan for 2025, an increase of 42.63% year-on-year [22] - Yongxi Electronics reported a net profit attributable to shareholders of 82.2403 million yuan for 2025, an increase of 23.99% year-on-year [22] Shareholding Changes - Asia Optical's shareholders plan to reduce their holdings by no more than 1.6 million shares [22] - Anhui Conch Cement's controlling shareholder plans to increase its holdings by 700 million to 1.4 billion yuan [22] - Huaneng Hydropower's controlling shareholder plans to increase its holdings by 100 million to 150 million yuan [22] - Fushi Holdings' shareholders plan to reduce their holdings by no more than 2% [22] - Zhixin Precision's board members plan to reduce their holdings by no more than 1.8562% [22] - Hongbaoli's deputy general manager plans to reduce their holdings by no more than 310,000 shares [22] - Yuanli Co. plans to repurchase shares worth 50 million to 60 million yuan [22] - Zhongshun Jierou plans to repurchase shares worth 60 million to 120 million yuan [22] Contract Awards - Fengfan Co. won a procurement project from Southern Power Grid worth approximately 184 million yuan [22] - Shaoneng Co.'s wholly-owned subsidiary signed a cooperation agreement for land and resources for an independent energy storage power station project with Yuancan Company [22] Major Investments - Zhejiang Medicine plans to invest 250 million yuan in a silver economy fund in collaboration with a private equity fund [4] Project Approvals - Gansu Energy's Minqin Shuangchike 2 million kilowatt wind power project has been approved [5] - China Tianying received investment approval for the expansion of its Hanoi project [5] Mergers and Acquisitions - Dazhu Laser plans to invest 150 million USD to establish an overseas operation center [6] - Dongyang Sunshine is planning to acquire control of Dongshu No. 1, with stock suspension [6] - Shenlian Bio plans to acquire control of Shizhi Source for 237 million yuan to fully develop its innovative drug business [23] - Tongwei is planning to purchase 100% of Lihua Qingneng, with stock suspension starting tomorrow [23] - Changxin Bochuang plans to acquire 93.8108% of Shanghai Honghui Optical Communication Technology Co., Ltd. for 375 million yuan [23] - Kaipu Cloud has terminated the acquisition of 100% of Nanning Taike [23] Other Developments - Kexin Mechanical and Electrical obtained a production license for ultra-high pressure containers (A6) [10] - Baiyin Nonferrous Metals received a government subsidy of 9 million yuan [24] - Rundou Co. received a drug registration certificate for ibuprofen tablets [25] - Hengrui Medicine's application for the marketing authorization of the innovative drug SHR-1918 injection has been accepted and included in the priority review process [26] - Duorui Medicine's tender offer period has expired, and the company's stock is suspended [27] - Inner Mongolia Huadian plans to apply for a change of its stock name to "Huaneng Mengdian" [28]

登录新浪财经APP 搜索【信披】查看更多考评等级 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 特别提示： 本公告所载2025年度财务数据仅为初步核算数据，已经公司内部审计部门审计，未经会计师事务所审 计，与年度报告中披露的最终数据可能存在差异，请投资者注意投资风险。 一、2025年度主要财务数据 单位：万元 ■ 注：以上数据以公司合并报表数据填列。 二、经营业绩和财务状况的情况说明 2025年公司实现营业收入2,277,175.35万元，较上年同期增长1.54%；利润总额258,752.72万元，较上年 同期下降5.30%；归属于上市公司股东的净利润209,672.02万元，较上年同期下降6.58%；其中： 1、营业总收入较同期增长1.54%。内销业务，面对复杂的国内市场环境与消费者更理性的市场需求， 公司通过持续创新及强大的渠道竞争优势，营业收入较同期稳定增长，且核心品类的线上、线下市场占 有率保持领先。外销业务，公司主要外销客户的订单较同期略有减少，营业收入较同期略微下降。 2、归属于上市公司股东的净利润较同期下降6.58%，主要因出口业务的综合影响， ...

免责声明：本文内容与数据仅供参考，不构成投资建议，使用前请核实。据此操作，风险自担。 （记者 王瀚黎） 每经AI快讯，苏泊尔2月24日晚间发布2025年度业绩快报，营业收入约227.72亿元，同比增加1.54%；归 属于上市公司股东的净利润约20.97亿元，同比减少6.58%；基本每股收益约2.63元，同比减少6.6%。 每日经济新闻 每经头条（nbdtoutiao）——伤亡180万人！俄乌冲突四周年，陷入谈判死局、战场僵局、经济困局！谁 为战争买单 ...

Major Announcements - Light Media's film "Fast and Furious 3" has achieved a cumulative box office revenue of approximately 2.926 billion yuan, with the company's revenue from this film estimated between 43 million to 53 million yuan, which exceeds 50% of the company's audited consolidated financial statement revenue for the most recent fiscal year [1] - Dazhong Laser plans to invest 150 million USD to establish an overseas operation center in Southeast Asia to enhance service capabilities and meet international market demands [1] - Shunlian Bio intends to acquire controlling interest in Yanzhou Shizhi Source Biotechnology Co., Ltd. for 237 million yuan, aiming to fully develop its innovative drug business [2] - Shaoneng Co. signed a cooperation agreement with Yuancan Company for an independent energy storage power station project, with a total agreement amount of 22 million yuan [3] - China Tianying received investment approval for the expansion of its waste-to-energy project in Hanoi, with an investment amount of approximately 220 million USD [4] - Gansu Energy's 2 million kW wind power project has received approval from the local development and reform bureau [5] - Kexin Machinery obtained a production license for ultra-high pressure vessels [6] Financial Performance - Zhongwei Semiconductor reported a net profit of 285 million yuan for 2025, a year-on-year increase of 108.05%, with total revenue of 1.122 billion yuan, up 23.09% [9] - Weidao Nano reported a net profit of 213 million yuan for 2025, a year-on-year decrease of 6.12%, with total revenue of 2.632 billion yuan, down 2.52% [10] - Wens Foodstuff Group reported a net profit of 5.235 billion yuan for 2025, a year-on-year decrease of 43.59%, with total revenue of 103.884 billion yuan, down 1.67% [11] - SanSheng Guojian reported a net profit of 2.939 billion yuan for 2025, a year-on-year increase of 317.09%, with total revenue of 4.199 billion yuan, up 251.81% [12] - Yongxi Electronics reported a net profit of 82.24 million yuan for 2025, a year-on-year increase of 23.99%, with total revenue of 4.4 billion yuan, up 21.92% [14] - YaoMai Technology reported a net profit of 137 million yuan for 2025, a year-on-year increase of 42.63%, with total revenue of 619 million yuan, up 24.33% [15] - Zhongke Shuguang reported a net profit of 2.113 billion yuan for 2025, a year-on-year increase of 10.54%, with total revenue of 14.97 billion yuan, up 13.86% [15] Shareholder Actions - Zhongshun Jierou plans to repurchase shares worth between 60 million to 120 million yuan for employee stock ownership plans [21] - Yuanli Co. plans to repurchase shares worth between 50 million to 60 million yuan for stock incentive plans [21] - Huaneng Hydropower's controlling shareholder plans to increase its stake by 100 million to 150 million yuan [22] - Conch Cement's controlling shareholder plans to increase its stake by 700 million to 1.4 billion yuan [23] Stock Suspension - Dongyangguang announced a stock suspension due to plans to acquire control of Dongshu No. 1 [29] - Tongwei Co. announced a stock suspension due to plans to acquire 100% equity of Qinghai Lihua Qingneng [30] - Duorui Pharmaceutical announced a stock suspension as the offer period for its acquisition has expired [31]

2月24日晚间，苏泊尔披露了2025年业绩快报，经初步核算数据，2025年其营收227.72亿元，同比微增1.54%；利润总额25.88亿元，较上年同期下降 5.30%；归属于上市公司股东的净利润20.97亿元，同比下降6.58%。 具体来看，苏泊尔的主要业务包括明火炊具及厨房用具、厨房小家电、厨卫电器、生活家居电器四大领域。从收入结构来看，公司长期依赖"厨房场 景"。近年来，苏泊尔烹饪电器、炊具及用具两项产品合计贡献近七成营收。若叠加食物料理电器，其厨房类业务占比进一步攀升，以2025年半年为例，上 述三类产品合计占比总营收超85%。 但当下厨房小家电及炊具行业竞争激烈，苏泊尔面临着传统品牌和新兴品牌的双重冲击。拉长时间线来看，2020年—2024年，苏泊尔归母净利润从 18.46亿元一路增长至22.44亿元。然而，2025年三季报显示，苏泊尔当季实现营收54.20亿元，同比下滑2.30%；归母净利润4.26亿元，同比下滑13.42%。这 | 项目 | 本报告期 | 上年同期 | 增减变动幅度( | | --- | --- | --- | --- | | 营业总收入 | 2,277,175.35 | 2,2 ...

看推文多多留言 有机会获商报君送出的礼品 2月24日晚，厨房小家电龙头企业苏泊尔披露2025年业绩快报。财务数据显示，2025年公司实现营业收入227.72亿元，同比增长1.54%；归属于上市公司股 东的净利润20.97亿元，同比下降6.58%；扣非净利润19.14亿元，同比下降7.30%。值得一提的是，这是苏泊尔自2021年以来首次出现年度归母净利润同比 下滑。 | | | | 单位: 万元 | | --- | --- | --- | --- | | 项目 | 本报告期 | 上年同期 | 增减变动幅度(%) | | 营业总收入 | 2,277,175.35 | 2,242,733.8 | 1.54% | | 营业利润 | 258,778.34 | 273,227.06 | -5.29% | | 利润总额 | 258.752.72 | 273.235.71 | -5 30% | | 归属于上市公司股东的净利润 | 209,672.02 | 224,444,45 | -6.58% | | 归属于上市公司股东的 扣除非经常性损益的净利润 | 191.399.99 | 206.469.88 | -7 30% | | ...

证券日报网讯 2月24日，苏泊尔发布2025年度业绩快报称，公司2025年实现营业总收入2277175.35万 元，同比增长1.54%；归属于上市公司股东的净利润209672.02万元，同比下降6.58%。 （文章来源：证券日报） ...

Group 1 - Hengyu Environmental reported a revenue of 294 million yuan for 2025, an increase of 89.87%, and a net profit of 35.93 million yuan, up 106.25% year-on-year [1] - Yongxi Electronics achieved a revenue of 4.4 billion yuan in 2025, a growth of 21.92%, with a net profit of 82.24 million yuan, reflecting a year-on-year increase of 23.99% [2] - Zhongwei Semiconductor reported a revenue of 1.122 billion yuan for 2025, a 23.09% increase, and a net profit of 285 million yuan, up 108.05% year-on-year [3] - Sry New Materials achieved a revenue of 1.564 billion yuan in 2025, a growth of 17.66%, with a net profit of 154 million yuan, reflecting a year-on-year increase of 35.04% [14] - Jiaokong Technology reported a revenue of 2.537 billion yuan for 2025, a growth of 16.08%, and a net profit of 156 million yuan, up 86.13% year-on-year [15] - SanSheng Guojian reported a revenue of 4.199 billion yuan for 2025, a significant increase of 251.81%, with a net profit of 2.939 billion yuan, up 317.09% year-on-year [30] Group 2 - Aidi Pharmaceutical reported a revenue of 721 million yuan for 2025, a growth of 72.49%, but incurred a net loss of 19.73 million yuan, reducing losses from 142 million yuan in the previous year [5] - Weidao Nano reported a revenue of 2.632 billion yuan for 2025, a decrease of 2.52%, with a net profit of 213 million yuan, down 6.12% year-on-year [9] - Wens Foodstuff Group reported a revenue of 103.884 billion yuan for 2025, a decline of 1.67%, with a net profit of 5.235 billion yuan, down 43.59% year-on-year [29] - Supor reported a revenue of 22.772 billion yuan for 2025, a growth of 1.54%, with a net profit of 2.097 billion yuan, down 6.58% year-on-year [33] Group 3 - ShaoNeng Co. signed a significant operational contract worth 22 million yuan for a biomass power generation project [6] - Shunlian Bio plans to use 237 million yuan to acquire controlling interest in a joint venture, increasing its stake from 16.99% to 51% [7] - Huason Pharmaceutical's subsidiary received clinical trial approval for an innovative drug, indicating progress in its product pipeline [8] - Xinyang Technology's subsidiary received a medical device registration certificate, enhancing its product offerings [10][11] - Yida Co. obtained an investment project filing certificate for a chemical production project with a total investment of 642 million yuan [12]